Chai
Santa Clara
About Chai
Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen, gene, species, or DNA tracer on-site at the point of need. Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Seed (Apr 2017)
- Website: chaibio.com
- Phone: (650) 779-5577
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/chai-69893 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.